ArticleJournal of diabetes investigation2026
Association of glucagon-like peptide-1 receptor agonist use with clinical outcomes in patients with rheumatoid arthritis and type 2 diabetes.
Yu-Ting Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.